Orchid Cellmark Inc. - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 37 PAGES: 30

More Info
									           Orchid Cellmark Inc. - Financial and Strategic SWOT Analysis Review
        Reference Code: GDPH133546FSA                                                                                            Publication Date: SEP 2012

          4390 US Route One                                  Phone              +1 609 7502200                      Revenue        NA
          Princeton, NJ                                      Fax                +1 609 7506405                      Net Profit     -4.52 (million USD)
          08540                                              Website            www.orchidcellmark.com              Employees      NA
                                                                                                                                   Pharmaceuticals             &
          United States                                      Exchange                                               Industry
                                                                                                                                   Healthcare

       Company Overview
       Orchid Cellmark Inc. (Orchid Cellmark) is a subsidiary of Laboratory Corporation of America Holdings and is one of the leading
       international providers of identity DNA testing services. It offers DNA testing services in forensic and family relationship
       applications. Its specialized forensic DNA testing services are used by the criminal justice system to assist in the identification of
       criminals, exclusion of suspects and the acquittal of wrongfully convicted individuals. It offers DNA family relationship testing to
       several child service organizations and individuals seeking to find out parentage.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Orchid Cellmark Inc., SWOT Analysis
         David P. King                       Chairman,       Laboratory               Strengths                                Weaknesses
                                             Corporation of America
                                                                                      Broad Range of DNA Testing               Legal Disputes
         James T. Boyle                      Chief Operating Officer,
                                                                                      Services
                                             Laboratory Corporation of
                                             America                                  Wide Technology Applications
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData
                                                                                      Opportunities                            Threats
       Share Data
         Orchid Cellmark Inc.                                                         Emerging Genetic Markets                 Competitive Pressures
        Share Price (USD) as on 15-Dec-                                  2.79         Strategic Partnerships                   Rapid Technological Change
        2011
        EPS (USD)                                                       -0.15
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        Market Cap (million USD)                                           84        GlobalData

        Enterprise Value (million USD)                                     79
        Shares Outstanding (million)                                       30
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Mar 10, 2011         Orchid Cellmark Reports Total Revenues Of
                                                                                                           $63.7m In 2010
                                                                                      Jan 18, 2011         Orchid Cellmark Receives DNA Paternity
                                                                                                           Testing Services Contract From CMEC
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData




       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




Orchid Cellmark Inc. - Financial and Strategic SWOT Analysis                                                                     Reference Code: GDPH133546FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                         Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Section 1 - About the Company.......................................................................................................................................................... 4
       Orchid Cellmark Inc. - Key Facts ........................................................................................................................................................ 4
       Orchid Cellmark Inc. - Key Employees ............................................................................................................................................... 5
       Orchid Cellmark Inc. - Major Products and Services .......................................................................................................................... 6
       Orchid Cellmark Inc. - History............................................................................................................................................................. 7
       Orchid Cellmark Inc. - Company Statement ....................................................................................................................................... 9
       Orchid Cellmark Inc. - Locations And Subsidiaries........................................................................................................................... 11
          Head Office ................................................................................................................................................................................... 11
          Other Locations & Subsidiaries ..................................................................................................................................................... 11
       Section 2 – Company Analysis ......................................................................................................................................................... 12
       Orchid Cellmark Inc. - Business Description .................................................................................................................................... 12
       Orchid Cellmark Inc. - SWOT Analysis ............................................................................................................................................. 13
          SWOT Analysis - Overview........................................................................................................................................................... 13
          Orchid Cellmark Inc. - Strengths ................................................................................................................................................... 13
             Strength - Broad Range of DNA Testing Services .................................................................................................................... 13
             Strength - Wide Technology Applications.................................................................................................................................. 13
          Orchid Cellmark Inc. - Weaknesses .............................................................................................................................................. 13
             Weakness - Legal Disputes....................................................................................................................................................... 13
          Orchid Cellmark Inc. - Opportunities ............................................................................................................................................. 13
             Opportunity - Emerging Genetic Markets .................................................................................................................................. 13
             Opportunity - Strategic Partnerships ......................................................................................................................................... 14
          Orchid Cellmark Inc. - Threats ...................................................................................................................................................... 14
             Threat - Competitive Pressures ................................................................................................................................................. 14
             Threat - Rapid Technological Change ....................................................................................................................................... 14
       Orchid Cellmark Inc. - Key Competitors ........................................................................................................................................... 15
       Section 3 – Company Financial Ratios ............................................................................................................................................. 16
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 16
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 16
       Performance Chart ........................................................................................................................................................................... 18
       Financial Ratios - Interim Ratios....................................................................................................................................................... 19
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 20
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 21
          Orchid Cellmark Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012............................................................ 21
          Orchid Cellmark Inc., Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012 ........................................................... 22
       Orchid Cellmark Inc., Recent Deals Summary ................................................................................................................................. 23
       Section 5 – Company’s Recent Developments ................................................................................................................................ 24
          Orchid Cellmark Inc., Recent Developments ................................................................................................................................ 24
             Mar 10, 2011: Orchid Cellmark Reports Total Revenues Of $63.7m In 2010 ........................................................................... 24
             Jan 18, 2011: Orchid Cellmark Receives DNA Paternity Testing Services Contract From CMEC ............................................ 25
       Section 6 – Appendix ....................................................................................................................................................................... 26
          Methodology ............................................................................................
								
To top